Drugs / 123-I AV151
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00556660 | Sep 2007 → Jul 2008 | Alzheimer disease | Institute for Neurodegenerative Disorders | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 123-I AV151 | “To assess the dynamic uptake and washout of 123-I AV151, a potential imaging biomarker for β-amyloid burden in brain, using single photon emission computed tomography (SPECT)...” NCT00556660 ↗ |
| Modality | Diagnostic / imaging agent | “a potential imaging biomarker for β-amyloid burden in brain” NCT00556660 ↗ |